OVID Stock Analysis: Buy, Sell, or Hold?

OVID - Ovid Therapeutics Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$2.30
-0.16 (-6.50%) ▼
5d: -12.21%
30d: +39.39%
90d: +29.92%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation

OVID is down 5.6% this week, but smart money is accumulating calls. Top strike: $2 2026-04-17 with 631 OI. Call ratio: 89% View Scanner →

Strength: 6.7/10

Get Alerted When OVID Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: OVID is down 12.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: OVID is currently trading at $2.30, which is considered slightly high relative to its 30-day fair value range of $1.57 to $2.30.

Technical Outlook: Technically, OVID is in a strong uptrend. Immediate support is located at $1.89, while resistance sits at $2.72. Short-term momentum is weak, with the stock down 6.5% recently.

Market Sentiment: OVID has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.55 (+97.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $1.57 - $2.30
Company Quality Score 61/100 (BUY)
Volume Confirmation HIGH
Confidence Score 73.7%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.5%)
  • BULLISH: Trading 97.8% below Wall St target ($4.55)
  • WARNING: Recommendation downgraded due to -12.2% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $1.57 - $2.30
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $1.89
Resistance Level $2.72
Current Trend Strong Uptrend
Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) -4.55
Wall Street Target $4.55 (+97.8%)
Revenue Growth (YoY) 844.7%
Profit Margin -240.1%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 8:55 AM ET
Data refreshes hourly during market hours. Next update: 9:55 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for OVID.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$21 65 BUY
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1018 56 HOLD
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$547 42 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$30 54 HOLD

More Analysis for OVID

OVID Technical Chart OVID Price Prediction OVID Earnings Date OVID Investment Advisor OVID Fair Price Analyzer OVID Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals